Merit Medical Systems (MMSI) Stock Forecast, Price Target & Predictions
MMSI Stock Forecast
Merit Medical Systems stock forecast is as follows: an average price target of $93.38 (represents a -2.89% downside from MMSI’s last price of $96.16) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
MMSI Price Target
The average price target for Merit Medical Systems (MMSI) is $93.38 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $125.00 to $71.00. This represents a potential -2.89% downside from MMSI's last price of $96.16.
MMSI Analyst Ratings
According to 4 Wall Street analysts, Merit Medical Systems's rating consensus is 'Buy'. The analyst rating breakdown for MMSI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 2 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Merit Medical Systems Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 09, 2024 | Jason Bednar | Piper Sandler | $110.00 | $96.58 | 13.90% | 14.39% |
| Aug 05, 2024 | Craig Bijou | Bank of America Securities | $92.00 | $87.44 | 5.22% | -4.33% |
| Aug 02, 2024 | Jason Bednar | Piper Sandler | $100.00 | $86.86 | 15.13% | 3.99% |
| Jul 02, 2024 | John Young | Canaccord Genuity | $125.00 | $85.64 | 45.96% | 29.99% |
| Jun 13, 2024 | Larry Biegelsen | Wells Fargo | $85.00 | $83.25 | 2.10% | -11.61% |
| May 01, 2024 | Jason Bednar | Piper Sandler | $97.00 | $77.12 | 25.78% | 0.87% |
| Apr 11, 2024 | Kristen Stewart | C.L. King | $88.00 | $71.95 | 22.31% | -8.49% |
| Oct 27, 2023 | Mike Matson | Needham | $81.00 | $68.83 | 17.68% | -15.77% |
| Jul 06, 2023 | Michael Petusky | Barrington | $95.00 | $79.35 | 19.72% | -1.21% |
| Jun 09, 2023 | Mike Matson | Needham | $96.00 | $83.81 | 14.54% | -0.17% |
The latest Merit Medical Systems stock forecast, released on Sep 09, 2024 by Jason Bednar from Piper Sandler, set a price target of $110.00, which represents a 13.90% increase from the stock price at the time of the forecast ($96.58), and a 14.39% increase from MMSI last price ($96.16).
Merit Medical Systems Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 4 | 8 |
| Avg Price Target | $110.00 | $106.75 | $97.25 |
| Last Closing Price | $96.16 | $96.16 | $96.16 |
| Upside/Downside | 14.39% | 11.01% | 1.13% |
In the current month, the average price target of Merit Medical Systems stock is $110.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 14.39% increase as opposed to Merit Medical Systems's last price of $96.16. This month's average price target is up 3.04% compared to last quarter, and up 13.11% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 09, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 28, 2024 | Needham | Underperform | Underperform | Hold |
| Aug 28, 2024 | Piper Sandler | Buy | Buy | Hold |
| Aug 05, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
| Aug 02, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 02, 2024 | Canaccord Genuity | Underperform | Underperform | Hold |
| Aug 02, 2024 | Needham | Buy | Buy | Hold |
| Jul 02, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Jun 28, 2024 | Piper Sandler | Buy | Buy | Hold |
| Jun 28, 2024 | Needham | Underperform | Underperform | Hold |
Merit Medical Systems's last stock rating was published by Piper Sandler on Sep 09, 2024. The company gave MMSI a "Overweight" rating, the same as its previous rate.
Merit Medical Systems Financial Forecast
Merit Medical Systems Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $320.06M | $297.56M | $293.42M | $287.18M | - | $275.42M | $278.49M | $267.02M | $280.32M | $248.91M | $258.00M | $243.97M | $218.37M | $243.53M | $257.92M | $243.05M |
| Avg Forecast | $391.38M | $376.34M | $387.32M | $370.57M | $364.60M | $353.60M | $363.46M | $345.39M | $345.03M | $334.43M | $334.56M | $315.57M | $320.66M | $306.19M | $310.10M | $280.50M | $290.14M | $272.52M | $280.55M | $264.38M | $270.91M | $260.61M | $250.60M | $230.88M | $250.47M | $217.63M | $192.67M | $231.57M | $252.31M | $248.55M |
| High Forecast | $393.84M | $378.71M | $389.76M | $372.91M | $366.90M | $355.83M | $365.75M | $347.57M | $347.21M | $336.70M | $336.67M | $317.56M | $326.92M | $308.12M | $312.06M | $282.27M | $291.97M | $274.24M | $280.55M | $266.53M | $273.11M | $262.73M | $252.64M | $232.76M | $252.50M | $219.40M | $194.24M | $233.45M | $254.36M | $250.57M |
| Low Forecast | $385.07M | $370.27M | $381.08M | $364.59M | $358.72M | $347.90M | $357.60M | $339.83M | $339.47M | $332.10M | $329.17M | $310.48M | $315.80M | $301.25M | $305.10M | $275.97M | $285.46M | $268.13M | $280.55M | $262.58M | $269.07M | $258.84M | $248.90M | $229.32M | $248.77M | $216.15M | $191.36M | $230.00M | $250.60M | $246.87M |
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 4 | 5 | 5 | 6 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.06% | 1.01% | 1.05% | - | 1.04% | 1.03% | 1.02% | 1.12% | 1.08% | 1.03% | 1.12% | 1.13% | 1.05% | 1.02% | 0.98% |
Merit Medical Systems's average Quarter revenue forecast for Sep 23 based on 3 analysts is $306.19M, with a low forecast of $301.25M, and a high forecast of $308.12M. MMSI's average Quarter revenue forecast represents a -4.33% decrease compared to the company's last Quarter revenue of $320.06M (Jun 23).
Merit Medical Systems EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 4 | 5 | 5 | 6 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $56.55M | $51.23M | $55.84M | $43.46M | - | $42.49M | $44.96M | $39.03M | $32.27M | $38.70M | $42.02M | $26.61M | $7.34M | $27.61M | $22.07M | $24.57M |
| Avg Forecast | $46.37M | $44.59M | $45.89M | $43.91M | $43.20M | $41.90M | $43.06M | $40.92M | $40.88M | $39.63M | $39.64M | $40.35M | $37.99M | $36.28M | $36.74M | $36.68M | $34.38M | $35.13M | $33.24M | $33.34M | $28.53M | $31.94M | $20.98M | $23.65M | $29.68M | $21.37M | $16.04M | $16.35M | $18.18M | $33.86M |
| High Forecast | $46.67M | $44.87M | $46.18M | $44.18M | $43.47M | $42.16M | $43.34M | $41.18M | $41.14M | $39.90M | $39.89M | $48.41M | $38.74M | $36.51M | $36.97M | $44.01M | $34.59M | $42.16M | $33.24M | $40.01M | $34.24M | $38.32M | $25.17M | $28.38M | $29.92M | $25.64M | $19.25M | $19.62M | $21.81M | $40.63M |
| Low Forecast | $45.63M | $43.87M | $45.15M | $43.20M | $42.50M | $41.22M | $42.37M | $40.27M | $40.22M | $39.35M | $39.00M | $32.28M | $37.42M | $35.69M | $36.15M | $29.34M | $33.82M | $28.10M | $33.24M | $26.67M | $22.82M | $25.55M | $16.78M | $18.92M | $29.48M | $17.09M | $12.83M | $13.08M | $14.54M | $27.09M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.54% | 1.40% | 1.62% | 1.24% | - | 1.27% | 1.58% | 1.22% | 1.54% | 1.64% | 1.42% | 1.25% | 0.46% | 1.69% | 1.21% | 0.73% |
3 analysts predict MMSI's average Quarter EBITDA for Sep 23 to be $36.28M, with a high of $36.51M and a low of $35.69M. This is -35.84% lower than Merit Medical Systems's previous annual EBITDA (Jun 23) of $56.55M.
Merit Medical Systems Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 4 | 5 | 5 | 6 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $20.25M | $20.70M | $33.40M | $15.27M | - | $10.54M | $20.61M | $11.97M | $4.92M | $10.96M | $15.38M | $-3.01M | $-19.06M | $-3.15M | $-4.21M | $-3.40M |
| Avg Forecast | $64.78M | $61.04M | $63.20M | $55.41M | $56.89M | $53.79M | $56.90M | $49.05M | $49.34M | $46.93M | $51.34M | $11.13M | $45.01M | $38.01M | $44.18M | $10.12M | $39.44M | $10.77M | $33.80M | $9.20M | $13.08M | $9.79M | $3.20M | $6.70M | $25.32M | $-2.42M | $-41.66M | $-1.87M | $-3.46M | $-4.68M |
| High Forecast | $65.31M | $61.54M | $63.72M | $55.86M | $57.36M | $54.23M | $57.37M | $49.45M | $49.75M | $47.52M | $51.76M | $13.36M | $46.18M | $38.32M | $44.54M | $12.14M | $39.76M | $12.92M | $33.80M | $11.04M | $15.70M | $11.75M | $3.83M | $8.04M | $25.59M | $-1.93M | $-33.32M | $-1.49M | $-2.77M | $-3.75M |
| Low Forecast | $63.42M | $59.76M | $61.88M | $54.25M | $55.70M | $52.66M | $55.71M | $48.02M | $48.31M | $46.35M | $50.26M | $8.90M | $43.84M | $37.22M | $43.25M | $8.09M | $38.61M | $8.62M | $33.80M | $7.36M | $10.47M | $7.83M | $2.56M | $5.36M | $25.10M | $-2.90M | $-49.99M | $-2.24M | $-4.16M | $-5.62M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.46% | 2.05% | 0.85% | 1.42% | - | 1.15% | 1.58% | 1.22% | 1.54% | 1.64% | 0.61% | 1.25% | 0.46% | 1.69% | 1.21% | 0.73% |
Merit Medical Systems's average Quarter net income forecast for Sep 23 is $38.01M, with a range of $37.22M to $38.32M. MMSI's average Quarter net income forecast represents a 87.76% increase compared to the company's last Quarter net income of $20.25M (Jun 23).
Merit Medical Systems SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 4 | 5 | 5 | 6 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $100.93M | $90.14M | $83.24M | $89.78M | - | $84.02M | $76.63M | $86.47M | $91.56M | $81.02M | $79.93M | $72.22M | $66.77M | $78.81M | $82.09M | $86.94M |
| Avg Forecast | $117.50M | $112.99M | $116.29M | $111.26M | $109.47M | $106.16M | $109.12M | $103.70M | $103.59M | $100.41M | $100.45M | $88.68M | $96.27M | $91.93M | $93.10M | $80.62M | $87.11M | $77.83M | $84.23M | $73.29M | $48.63M | $70.75M | $59.52M | $49.51M | $75.20M | $57.98M | $145.93M | $46.68M | $67.60M | $119.78M |
| High Forecast | $118.25M | $113.70M | $117.02M | $111.96M | $110.16M | $106.83M | $109.81M | $104.35M | $104.24M | $101.09M | $101.08M | $106.42M | $98.15M | $92.51M | $93.69M | $96.74M | $87.66M | $93.39M | $84.23M | $87.95M | $58.36M | $84.90M | $71.42M | $59.42M | $75.81M | $69.57M | $175.12M | $56.01M | $81.13M | $143.73M |
| Low Forecast | $115.61M | $111.17M | $114.41M | $109.46M | $107.70M | $104.45M | $107.36M | $102.03M | $101.92M | $99.71M | $98.83M | $70.94M | $94.82M | $90.45M | $91.60M | $64.49M | $85.71M | $62.26M | $84.23M | $58.63M | $38.90M | $56.60M | $47.61M | $39.61M | $74.69M | $46.38M | $116.75M | $37.34M | $54.08M | $95.82M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.12% | 0.96% | 1.15% | - | 1.15% | 1.58% | 1.22% | 1.54% | 1.64% | 1.06% | 1.25% | 0.46% | 1.69% | 1.21% | 0.73% |
Merit Medical Systems's average Quarter SG&A projection for Sep 23 is $91.93M, based on 3 Wall Street analysts, with a range of $90.45M to $92.51M. The forecast indicates a -8.92% fall compared to MMSI last annual SG&A of $100.93M (Jun 23).
Merit Medical Systems EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 4 | 5 | 5 | 6 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.35 | $0.36 | $0.58 | $0.27 | - | $0.19 | $0.36 | $0.21 | $0.09 | $0.20 | $0.28 | $-0.05 | $-0.34 | $-0.06 | $-0.08 | $-0.06 |
| Avg Forecast | $1.10 | $1.04 | $1.08 | $0.94 | $0.97 | $0.92 | $0.97 | $0.83 | $0.84 | $0.80 | $0.87 | $0.71 | $0.77 | $0.65 | $0.75 | $0.55 | $0.67 | $0.53 | $0.58 | $0.47 | $0.51 | $0.44 | $0.45 | $0.36 | $0.43 | $0.20 | $0.07 | $0.26 | $0.34 | $0.45 |
| High Forecast | $1.11 | $1.05 | $1.08 | $0.95 | $0.98 | $0.92 | $0.98 | $0.84 | $0.85 | $0.81 | $0.88 | $0.72 | $0.79 | $0.65 | $0.76 | $0.55 | $0.68 | $0.53 | $0.58 | $0.47 | $0.51 | $0.44 | $0.45 | $0.36 | $0.44 | $0.20 | $0.07 | $0.26 | $0.35 | $0.45 |
| Low Forecast | $1.08 | $1.02 | $1.05 | $0.92 | $0.95 | $0.90 | $0.95 | $0.82 | $0.82 | $0.79 | $0.86 | $0.70 | $0.75 | $0.63 | $0.74 | $0.53 | $0.66 | $0.52 | $0.58 | $0.46 | $0.50 | $0.43 | $0.44 | $0.35 | $0.43 | $0.20 | $0.06 | $0.26 | $0.34 | $0.44 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.47% | 0.66% | 0.86% | 0.51% | - | 0.41% | 0.71% | 0.48% | 0.20% | 0.56% | 0.65% | -0.25% | -5.23% | -0.23% | -0.23% | -0.13% |
According to 3 Wall Street analysts, Merit Medical Systems's projected average Quarter EPS for Sep 23 is $0.65, with a low estimate of $0.63 and a high estimate of $0.65. This represents a 84.90% increase compared to MMSI previous annual EPS of $0.35 (Jun 23).
Merit Medical Systems Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $110.53 | $298.00 | 169.61% | Buy |
| ANGO | AngioDynamics | $7.64 | $17.00 | 122.51% | Buy |
| XRAY | DENTSPLY SIRONA | $26.28 | $40.00 | 52.21% | Buy |
| HAE | Haemonetics | $76.09 | $104.33 | 37.11% | Buy |
| TFX | Teleflex | $246.05 | $304.09 | 23.59% | Buy |
| NVST | Envista | $19.41 | $23.83 | 22.77% | Hold |
| WST | West Pharmaceutical Services | $300.67 | $345.33 | 14.85% | Buy |
| MMSI | Merit Medical Systems | $96.16 | $93.38 | -2.89% | Buy |
| ALC | Alcon | $98.50 | $93.34 | -5.24% | Buy |
| RMD | ResMed | $248.93 | $209.33 | -15.91% | Hold |
| ICUI | ICU Medical | $179.00 | $135.00 | -24.58% | Buy |
| ATR | AptarGroup | $152.28 | $100.00 | -34.33% | Buy |
MMSI Forecast FAQ
Is Merit Medical Systems a good buy?
Yes, according to 4 Wall Street analysts, Merit Medical Systems (MMSI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 50.00% of MMSI's total ratings.
What is MMSI's price target?
Merit Medical Systems (MMSI) average price target is $93.38 with a range of $71 to $125, implying a -2.89% from its last price of $96.16. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Merit Medical Systems stock go up soon?
According to Wall Street analysts' prediction for MMSI stock, the company can go down by -2.89% (from the last price of $96.16 to the average price target of $93.38), up by 29.99% based on the highest stock price target, and down by -26.16% based on the lowest stock price target.
Can Merit Medical Systems stock reach $140?
MMSI's average twelve months analyst stock price target of $93.38 does not support the claim that Merit Medical Systems can reach $140 in the near future.
What is Merit Medical Systems's current price target trend?
1 Wall Street analyst forecast a $110 price target for Merit Medical Systems (MMSI) this month, up 14.39% from its last price of $96.16. Compared to the last 3 and 12 months, the average price target increased by 11.01% and increased by 1.13%, respectively.
What are Merit Medical Systems's analysts' financial forecasts?
Merit Medical Systems's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.43B (high $1.44B, low $1.4B), average EBITDA is $169.09M (high $170.15M, low $166.36M), average net income is $216.63M (high $218.41M, low $212.09M), average SG&A $428.45M (high $431.16M, low $421.55M), and average EPS is $3.69 (high $3.72, low $3.61). MMSI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.53B (high $1.54B, low $1.5B), average EBITDA is $180.76M (high $181.91M, low $177.85M), average net income is $244.43M (high $246.44M, low $239.31M), average SG&A $458.04M (high $460.93M, low $450.66M), and average EPS is $4.16 (high $4.2, low $4.07).
Did the MMSI's actual financial results beat the analysts' financial forecasts?
Based on Merit Medical Systems's last annual report (Dec 2022), the company's revenue was $1.15B, beating the average analysts forecast of $1.11B by 3.92%. Apple's EBITDA was $194.67M, beating the average prediction of $136.09M by 43.04%. The company's net income was $74.52M, missing the average estimation of $93.21M by -20.06%. Apple's SG&A was $342.52M, beating the average forecast of $322.46M by 6.22%. Lastly, the company's EPS was $1.31, missing the average prediction of $2.24 by -41.59%. In terms of the last quarterly report (Jun 2023), Merit Medical Systems's revenue was $320.06M, beating the average analysts' forecast of $310.1M by 3.21%. The company's EBITDA was $56.55M, beating the average prediction of $36.74M by 53.90%. Merit Medical Systems's net income was $20.24M, missing the average estimation of $44.18M by -54.17%. The company's SG&A was $100.93M, beating the average forecast of $93.1M by 8.40%. Lastly, the company's EPS was $0.35, missing the average prediction of $0.752 by -53.46%